2022
DOI: 10.1016/j.arth.2022.01.026
|View full text |Cite
|
Sign up to set email alerts
|

Reducing Narcotic Usage With 0.5% Bupivacaine Periarticular Injections in Total Knee Arthroplasty

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 19 publications
0
4
0
Order By: Relevance
“…40 This finding has further been supported in a randomized control trial by Pic et al, 41 who found that PAI was noninferior to ACB. This has important implications that ACBs may be eliminated without compromising pain control, provided the local anesthetic dose in the PAI is adjusted in the absence of ACB as described by Hagar et al 40 This may also enhance the safety profile of anesthetic protocols as the surgical and anesthesia teams must be mindful of total anesthetic dosage, although a study of serum ropivacaine after combined subarachnoid, ACB, and PAI application maintained levels well below the 3.0 µg/mL toxicity levels. 42 The pharmacokinetic properties of local anesthetics are complex, and while cleared primarily through renal processing, nonrenal clearance is often able to accommodate.…”
Section: Periarticular Injection and Peripheral Nerve Blockmentioning
confidence: 63%
See 2 more Smart Citations
“…40 This finding has further been supported in a randomized control trial by Pic et al, 41 who found that PAI was noninferior to ACB. This has important implications that ACBs may be eliminated without compromising pain control, provided the local anesthetic dose in the PAI is adjusted in the absence of ACB as described by Hagar et al 40 This may also enhance the safety profile of anesthetic protocols as the surgical and anesthesia teams must be mindful of total anesthetic dosage, although a study of serum ropivacaine after combined subarachnoid, ACB, and PAI application maintained levels well below the 3.0 µg/mL toxicity levels. 42 The pharmacokinetic properties of local anesthetics are complex, and while cleared primarily through renal processing, nonrenal clearance is often able to accommodate.…”
Section: Periarticular Injection and Peripheral Nerve Blockmentioning
confidence: 63%
“…The authors found that patients receiving a higher concentration of bupivacaine in the PAI alone group had lower hospital narcotic usage compared with a lower concentration used for combined PAI and ACB. 40 This finding has further been supported in a randomized control trial by Pic et al, 41 who found that PAI was noninferior to ACB. This has important implications that ACBs may be eliminated without compromising pain control, provided the local anesthetic dose in the PAI is adjusted in the absence of ACB as described by Hagar et al 40 This may also enhance the safety profile of anesthetic protocols as the surgical and anesthesia teams must be mindful of total anesthetic dosage, although a study of serum ropivacaine after combined subarachnoid, ACB, and PAI application maintained levels well below the 3.0 mg/mL toxicity levels.…”
Section: Periarticular Injection and Peripheral Nerve Blockmentioning
confidence: 63%
See 1 more Smart Citation
“…The dose of bupivacaine in LIA used in our study was also less than in some other studies. Hagar et al injected bupivacaine at a dose ranging from 125 mg to 250 mg in their studies ( 3 ). Moreover, amounts as high as 300 mg of bupivacaine have also been reported in a study from Peterson et al without any occurrence of LAST ( 4 ).…”
mentioning
confidence: 99%